Lyme rarely acts alone. It often coexists with Bartonella, Babesia, Ehrlichia, Mycoplasma, Rickettsiae, and viruses such as Powassan, all of which exacerbate inflammation and neuroimmune dysfunction. These infections disrupt the immune system through biofilm formation, cytokine storms, and molecular mimicry, while simultaneously impairing gut barrier integrity; a condition known as ‘leaky gut.’ This state of immune chaos parallels the chronic inflammation seen in individuals exposed to genetically engineered foods and glyphosate residues.
Despite their shared roots in biotechnology, genetically modified foods and engineered pathogens are regulated separately by the USDA, EPA, FDA, NIH, and DOD, none of which coordinate holistic biosafety. This fragmented oversight allows both agricultural and biomedical engineering to advance without unified accountability. The same regulatory capture that shields agri-tech corporations has also protected infectious disease gatekeepers, such as the Infectious Disease Society of America (IDSA), whose restrictive guidelines have left millions of chronic Lyme patients untreated.
Just as the FDA dismisses independent research on GMO toxicity, the IDSA dismisses clinicians and patients suffering from persistent Lyme. Both systems denied chronic exposure or chronic infection, labelled dissenting experts as “fringe,” protecting corporate and institutional interests over public health. The pattern created is systemic and taken directly from the GMO playbook: create complexity, deny chronicity, and suppress those questioning the government/corporate narrative.